Impilo, a leader in next-generation connected care solutions, today announced its strategic expansion of physical operations ...

STOCKHOLM & LONDON--(BUSINESS WIRE)-- Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, ...

PHILADELPHIA, April 17, 2025 /PRNewswire/ -- Impilo, a leader in enabling at-home healthcare through connected device and diagnostics operations, is excited to announce it has joined the Elation ...

Impilo and SHS have acquired Lowenco, a maker of ultra-low temperature storage solutions for the pharmaceutical industry. No financial terms were disclosed. Brown Gibbons Lang & Company was financial ...

(RTTNews) - Demant A/S (DEMANT.CO, WILYY), a hearing healthcare group on Wednesday said it agreed to sell Oticon Medical to Impilo, a Nordic investment company for a contractual consideration of up to ...

KKR has agreed to buy into Immedica Pharma, a pharmaceutical company focused on the commercialization of medicines for rare diseases and speciality care products. Immedica’s existing owner Impilo will ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Impilo started the year with 35 ...

STOCKHOLM, Sept. 16, 2021 /PRNewswire/ -- Impilo AB, the Nordic investment company focused on healthcare investments, has secured new commitments from new and existing investors of SEK 6bn (EUR 590m) ...